Company overview
Made Scientific, formerly BioCentriq, is a CDMO specializing in cell therapy development and manufacturing for pharmaceutical and biotech companies. It provides process and analytical development, GMP drug substance and product manufacturing, aseptic fill and finish, quality control testing, and workforce training. Facilities in New Jersey, including a 60,000 sq. ft. Princeton site with six ISO 7 cleanrooms, support clinical to commercial-scale production of modalities like CAR-T, NK cells, iPSC, and MSC therapies.
Cell Therapy CDMO is listed in the NovaPharmaNews Supplier Hub as a CDMO & Manufacturing partner serving United States & Americas. Core focus areas include cell therapy cdmo, gmp manufacturing, car-t manufacturing, ipsc cell therapy, cell therapy development.
Industry categories: CDMO & Manufacturing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Cell Therapy CDMO include Cdmo — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://madescientific.com
- Categories
- CDMO & Manufacturing
- Markets served
- United States & Americas
- Keywords
- cell therapy cdmo, gmp manufacturing, car-t manufacturing, ipsc cell therapy, cell therapy development
Products & technologies
Therapeutic areas
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What cell therapy services do you offer?
- Comprehensive services including process and analytical development, GMP drug substance and product manufacturing, aseptic fill and finish, quality control release testing, stability studies, and workforce training.
- What regulatory standards do your facilities meet?
- Facilities operate under current GMP regulatory standards and industry guidelines, with ISO 7 cleanrooms equipped for clinical and commercial manufacturing.
- What are your geographic locations and capacities?
- New Jersey-based with facilities in Princeton (60,000 sq. ft. headquarters, six ISO 7 cleanrooms, 30,000 sq. ft. expansion space) and Newark (GMP production and training), supporting T-cell, NK, iPSC, and MSC therapies.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
